Your browser doesn't support javascript.
loading
Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2.
Hakoi, Haruka; Miki, Yoshimi; Nomura, Saki; Nakajima, Kimiko; Terashima-Murase, Chiaki; Takeichi, Takuya; Sano, Shigetoshi; Akiyama, Masashi; Sakasegawa, Shin-Ichi; Murakami, Makoto; Yamamoto, Kei.
Affiliation
  • Hakoi H; Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan. Electronic address: hakoi501504001@gmail.com.
  • Miki Y; Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan; Laboratory of Microenvironmental Metabolic Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University
  • Nomura S; Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan. Electronic address: c702232009@tokushima-u.ac.jp.
  • Nakajima K; Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan. Electronic address: nakajimk@kochi-u.ac.jp.
  • Terashima-Murase C; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: chiaki-m@med.nagoya-u.ac.jp.
  • Takeichi T; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: takeichi@med.nagoya-u.ac.jp.
  • Sano S; Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan. Electronic address: sano.derma@kochi-u.ac.jp.
  • Akiyama M; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: makiyama@med.nagoya-u.ac.jp.
  • Sakasegawa SI; Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan; Asahi Kasei Pharma Corporation, Shizuoka, Japan. Electronic address: sakasegawa.sb@aist.go.jp.
  • Murakami M; Laboratory of Microenvironmental Metabolic Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan. Electronic address: makmurak@m.u-tokyo.ac.
  • Yamamoto K; Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan; AMED-PRIME, Japan Agency for Medical Research and Development, Tokyo, Japan. Electronic address: kei@tokushima-u.ac.jp.
Biochimie ; 215: 75-87, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37802209
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Phospholipases A2, Secretory Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Biochimie Year: 2023 Document type: Article Country of publication: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Phospholipases A2, Secretory Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Biochimie Year: 2023 Document type: Article Country of publication: Francia